A photo of Charu Venkatesan.

Fetal and Neonatal Neurology Specialist, Division of Neurology

Associate Professor, UC Department of Pediatrics


Board Certified

"I like to understand each child’s neurological condition and the unique challenges presented to the child and family, so I can help them navigate hurdles presented by the medical condition."

My Biography & Research


I have always been fascinated by the intricate and complex design of the brain that endows each individual with unique qualities, and how disruption of neural connections can lead to neurological deficits. I also have a long-standing interest in brain development.

As a pediatric neurologist, I specialize in fetal and neonatal neurology and see patients both in the hospital and in clinic. I like to understand each child’s neurological condition and the unique challenges presented to the child and family, so I can help them navigate hurdles presented by the medical condition.

I also see patients with common neurological conditions such as headaches, developmental delays and seizures. I have always enjoyed working with children and families, and I especially enjoy taking care of children from infancy until adulthood while getting to know their families.

In addition to my clinical practice, I am also the Neonatal Neurology Fellowship director at Cincinnati Children’s Hospital Medical Center. I enjoy teaching very much and have been awarded the M. Harold Fogelson Teaching Award in 2016 by the Division of Neurology.

My research evaluates the outcomes of infants with congenital brain malformations and perinatal brain injury. This research aims to provide better counseling for families and improve medical care for children with these conditions.

I enjoy spending my free time with my husband and children.

Additional Languages

Spanish, Tamil

Clinical Interests

Pediatric neurology; fetal neurology; neonatal neurology

Research Interests

Neonatal brain injury

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions


Research Divisions


My Locations

My Education

BA: Columbia University, NY, NY, 1992.

PhD: State University of NY at Stony Brook, Stony Brook, NY, 2000.

MD: State University of NY at Stony Brook, Stony Brook, NY, 2002.

Residency: Pediatrics, Northwestern University, Chicago, IL, 2004.

Residency: Child Neurology, Northwestern University, Chicago, IL, 2007.

Certification: Neurology with Special Qualifications in Child Neurology, 2008.

My Publications

Prenatal evaluation of the Sakoda complex. Nagaraj, UD; Moudgal, R; Hopkin, RJ; Venkatesan, C; Kline-Fath, BM. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2019; 49:1843-1847.

Fetal brain MRI findings and neonatal outcome of common diagnosis at a tertiary care center. Arroyo, MS; Hopkin, RJ; Nagaraj, UD; Kline-Fath, B; Venkatesan, C. Journal of Perinatology. 2019; 39:1072-1077.

Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S-2 Transmembrane Segment: Clinical, Genetic, and Functional Features. Soldovieri, MV; Ambrosino, P; Mosca, I; Miceli, F; Franco, C; Canzoniero, LM T; Kline-Fath, B; Cooper, EC; Venkatesan, C; Taglialatela, M. International Journal of Molecular Sciences. 2019; 20:3382-3382.

Clinical, Neuroimaging, and Electrographic Predictors of Phenobarbital Failure in Newborns With Hypoxic Ischemic Encephalopathy and Seizures. Dwivedi, D; Lin, N; Venkatesan, C; Kline-Fath, B; Holland, K; Schapiro, M. Journal of Child Neurology. 2019; 34:458-463.

White Matter Lesions Detected by Magnetic Resonance Imaging in Neonates and Children With Congenital Myotonic Dystrophy. Peglar, LM; Nagaraj, UD; Tian, C; Venkatesan, C. Pediatric Neurology. 2019; 96:64-69.

Outcome of Isolated Absent Septum Pellucidum Diagnosed by Fetal Magnetic Resonance Imaging (MRI) Scan. Vawter-Lee, MM; Wasserman, H; Thomas, CW; Nichols, B; Nagaraj, UD; Schapiro, M; Venkatesan, C. Journal of Child Neurology. 2018; 33:693-699.

Conventional MRI scan and DTI imaging show more severe brain injury in neonates with hypoxic-ischemic encephalopathy and seizures. Kline-Fath, BM; Horn, PS; Yuan, W; Merhar, S; Venkatesan, C; Thomas, CW; Schapiro, MB. Early Human Development. 2018; 122:8-14.

Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy. Venkatesan, C; Young, S; Schapiro, M; Thomas, C. Journal of Child Neurology. 2017; 32:210-214.

KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients. Millichap, JJ; Park, KL; Tsuchida, T; Ben-Zeev, B; Carmant, L; Flamini, R; Joshi, N; Levisohn, PM; Marsh, E; Nangia, S; et al. Neurology Genetics. 2016; 2:e96-e96.

Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants. Venkatesan, C; Angle, B; Millichap, JJ. Epileptic Disorders: international epilepsy journal with videotape. 2016; 18:195-200.